BioCentury
ARTICLE | Company News

SuperGen, Wyeth sales and marketing update

June 12, 2006 7:00 AM UTC

The companies announced the early termination of WYE's rights to distribute SUPG's Nipent pentostatin outside the U.S. SUPG paid WYE a $2.1 million early termination fee. Nipent is marketed as monoth...